Injectable weight loss and diabetes therapies continue to thrive despite recent oral GLP-1 drug approvals. Experts said they ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

West Pharmaceutical Services reported better-than-expected quarterly earnings and revenue.

Explore the growing demand for GLP-1 weight-loss drugs shaped by online communities and consumer-driven choices outside ...

The acquisition of Kelonia Therapeutics, announced this week, is part of Lilly’s expansion into cancer treatments.

Amidst soaring demand for GLP-1 therapies, counterfeit Mounjaro injections worth Rs 70 lakh have been seized in Gurugram, ...

New IGD (Institute of Grocery Distribution) research reveals that uptake of GLP1 weight loss medications has almost doubled in the UK since June 2025, rising from 3.1% to 6% in March this year.

Hair loss is a potential side effect of weight loss medications, caused by a condition called telogen effluvium, which can be ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

Why some people are resistant to weight-loss drugs, according to a dietitian - Dietitian warns there are potential genetic ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

By targeting underlying synovitis, the novel intra-articular liraglutide formulation 4P004 aims to bridge the gap between transient symptom relief and disease modification in knee OA.